Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | LMNA | P02545 | 1/20 | 0.76 |
| ▸ | PKM | P14618 | 1/20 | 0.76 |
| ▸ | APEX1 | P27695 | 1/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.76 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.55 |
| ▸ | NPC1 | O15118 | 4/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | SNCA | P37840 | 1/20 | 0.54 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.54 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23190878 | 1.00 | POLB (0.76) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL16316028 | 0.91 | NPC1 (0.59) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL137276 | 0.87 | POLB (1.00) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL30319980 | 0.87 | POLB (1.00) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL9681496 | 0.87 | POLB (1.00) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL1353478 | 0.87 | POLB (1.00) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL2128727 | 0.87 | POLB (1.00) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL8442129 | 0.85 | POLB (0.96) | POLBMEN1KMT2ALMNAPKM | |
| Hydrochloric Acid SCHEMBL8640632 | 0.85 | POLB (0.96) | POLBMEN1KMT2ALMNAPKM | |
| SCHEMBL20787000 | 0.85 | POLB (0.73) | POLBMEN1KMT2ALMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676935-B2 | Polyoxymethylene resin composition | HYUNDAI MOTOR COMPANY (KR) | 2017-06-13 | — | — | US | disclosed |
| US-9342008-B2 | Fuser member compositions | XEROX CORPORATION (US) | 2016-05-17 | — | — | US | disclosed |
| US-20150198915-A1 | FUSER MEMBER COMPOSITIONS | XEROX CORPORATION (US) | 2015-07-16 | — | — | US | disclosed |
| US-20150184110-A1 | POLYOXYMETHYLENE RESIN COMPOSITION | KOREA ENGINEERING PLASTICS CO., LTD. (KR) | 2015-07-02 | — | — | US | disclosed |
| US-8921426-B2 | Cationic bis-urea compounds as effective antimicrobial agents | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-12-30 | — | — | US | disclosed |
| US-8901247-B2 | Responsive polymer system and nanohybrid thin films | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-12-02 | — | — | US | disclosed |
| US-20130281515-A1 | CATIONIC BIS-UREA COMPOUNDS AS EFFECTIVE ANTIMICROBIAL AGENTS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-10-24 | — | — | US | disclosed |
| US-8496616-B2 | Medical device employing liquid crystal block copolymers and method of making the same | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2013-07-30 | — | — | US | disclosed |
| US-20120220932-A1 | MEDICAL DEVICE EMPLOYING LIQUID CRYSTAL BLOCK COPOLYMERS AND METHOD OF MAKING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-08-30 | — | — | US | disclosed |
| US-8187492-B2 | Medical device employing liquid crystal block copolymers and method of making the same | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20080146773-A1 | Nucleophilic Acyl Substitution-based Polymerization Catalyzed by Mononuclear Oxometallic Complexes | NATIONAL TAIWAN NORMAL UNIVERSITY (TW) | 2008-06-19 | — | — | US | disclosed |
| EP-1889876-A1 | DOPE FOR MOLDING | TEIJIN LIMITED (JP) | 2008-02-20 | — | — | EP | disclosed |
| US-20070191813-A1 | Medical device employing liquid crystal block copolymers and method of making the same | BOSTON SCIENTIFIC SCIMED, INC. | 2007-08-16 | — | — | US | disclosed |
| US-20070191814-A1 | Medical device employing liquid crystal block copolymers and method of making the same | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2007-08-16 | — | — | US | disclosed |
| WO-2007042658-A1 | METHOD FOR THE MODIFICATION OF POLYMER SURFACES, SUCH AS THE HYDROXYLATION OF POLYMER SURFACES, AND PRODUCTS THUS OBTAINED | ALCHIMER (FR) | 2007-04-19 | — | — | WO | disclosed |
| US-20070021585-A1 | Nucleophilic Acyl Substitution-based Polymerization Catalyzed by Oxometallic Complexes | NATIONAL TAIWAN NORMAL UNIVERSITY (TW) | 2007-01-25 | — | — | US | disclosed |
| US-20070013102-A1 | Method for making polybenzobisoxazole containing fiber | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-01-18 | — | — | US | disclosed |
| US-20070015897-A1 | Method for making polybenzobisoxazole containing polymer | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-01-18 | — | — | US | disclosed |
| US-20070015899-A1 | Polybenzobisoxazole containing fiber | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-01-18 | — | — | US | disclosed |
| US-20070015898-A1 | Method for making polybenzobisoxazole containing polymer | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130281515-A1 | CATIONIC BIS-UREA COMPOUNDS AS EFFECTIVE ANTIMICROBIAL AGENTS | NOS3, NOS1, NOS2 | POLB 1098/4885MEN1 3679/4885KMT2A 2488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.